Health Mart Fexofenadine Hydrochloride 180mg Tablets Recall
Perrigo Company is recalling Health Mart Fexofenadine Hydrochloride 180mg antihistamine tablets due to failed impurity specifications detected during stability testing. The recall affects approximately 6,960 containers distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source text does not report any illnesses, injuries, or hospitalizations—only a failed specification during stability testing. This is a precautionary pharmaceutical recall based on manufacturing standards rather than confirmed patient harm, consistent with a Moderate severity rating.
Plain-English summary
Perrigo Company PLC is recalling Health Mart Fexofenadine Hydrochloride 24HR 180mg antihistamine tablets, 70-count bottles, due to impurity issues. During stability testing, an out-of-specification result was obtained for impurity A, indicating the product failed required purity standards.
The recalled product was distributed nationwide in the USA. The affected lot is 0FR0461 with an expiration date of 2/25/2022. Approximately 6,960 containers are involved in this recall. The product was distributed by McKesson of Irvine, Texas, and manufactured in the Czech Republic.
Consumers who have purchased this product should stop using it. Patients should consult their healthcare provider or pharmacist about obtaining a replacement or alternative antihistamine. The product is identified by NDC 62011-0233-1 and UPC 0 52569 13787 1.
The recalled product
- Product
- Health Mart, Fexofenadine Hydrochloride tablets, 24HR, 180mg . Antihistamine 70 count bottle, Distributed by: Mckesson 6555 State Highway 161, Irvine, TX 75039. Made in the Czech Republic, NDC 62011-0233-1, UPC 0 52569 13787 1
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Antihistamine Tablet
- Hazard
- impurity-degradation
- failed-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 0FR0461
- Exp 2/25/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27